Answers are grounded in this paper and cite their sources.
An intervention using salvianolic acid B reduces neurological injury in post-cardiac arrest, suggesting therapeutic potential.
SalB protects against CI/R-induced neurological injury by reducing oxidative stress, inflammation, and apoptosis through Nrf2 activation, supporting its potential as a therapeutic agent for post-CA cerebral injury.
No takes yet. Share an insight, caveat, or question.
Lv et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: